John L Schmitz
Overview
Explore the profile of John L Schmitz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
699
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chhetri S, Nance D, Loya M, Cornaby C, Markmann A, Schmitz J, et al.
Am J Trop Med Hyg
. 2024 Nov;
112(1):177-181.
PMID: 39531720
In the first 6 months of the coronavirus disease 2019 pandemic, limited testing clouded understanding of the extent of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission in Africa. In...
2.
Charnaya O, Ishaque T, Hallett A, Morris G, Coppage M, Schmitz J, et al.
Transplantation
. 2024 Sep;
PMID: 39233325
Background: HLA-DQ mismatch has been identified as a predictor of de novo donor-specific HLA antibody formation and antibody-mediated rejection. There are insufficient data to guide the incorporation of DQ mismatch...
3.
Mokashi N, Marusiak A, Giandomenico D, Cleinmark M, Schmitz J, Boyce R
Am J Trop Med Hyg
. 2024 Feb;
110(4):815-818.
PMID: 38412547
Delayed treatment of Rocky Mountain spotted fever is associated with increased morbidity and mortality. Because the diagnosis cannot be established from a single serological test, guidelines recommend empirical antibiotic initiation...
4.
Franz B, Register H, Sullivan V, Warber K, Granade T, Cornaby C, et al.
J Clin Microbiol
. 2024 Jan;
62(2):e0083623.
PMID: 38206000
HIV is an ongoing global epidemic with estimates of more than a million new infections occurring annually. To combat viral spread, continuous innovations in areas including testing and treatment are...
5.
Khanolkar A, Spiczka A, Bonfield T, Alexander T, Schmitz J, Boras D, et al.
Immunohorizons
. 2023 Aug;
7(8):600-610.
PMID: 37639224
It is indeed a privilege to be an immunologist in what is arguably the golden age of immunology. From astounding advances in fundamental knowledge to groundbreaking immunotherapeutic offerings, immunology has...
6.
Bartelt L, Markmann A, Nelson B, Keys J, Root H, Henderson H, et al.
mBio
. 2022 Sep;
13(5):e0175122.
PMID: 36135380
COVID-19 convalescent plasma (CCP) was an early and widely adopted putative therapy for severe COVID-19. Results from randomized control trials and observational studies have failed to demonstrate a clear therapeutic...
7.
Cornaby C, Giardina C, Schmitz J
J Immunol Methods
. 2022 Aug;
509:113340.
PMID: 36030829
Background: Detection of latent Mycobacterium tuberculosis (LTBI) in patients is important to prevent active infection and the spread of disease, particularly in vulnerable patient populations. In 2020, a kit on...
8.
Lopez C, Cunningham C, Pugh S, Brandt K, Vanna U, Delacruz M, et al.
mSphere
. 2022 May;
7(3):e0084121.
PMID: 35587682
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused millions of deaths around the world within the past 2 years. Transmission within the United States has been heterogeneously distributed by...
9.
Morgan C, Rimland C, Bell G, Kim M, Hedrick T, Marx A, et al.
Healthc (Amst)
. 2021 Oct;
9(4):100581.
PMID: 34626958
The interleukin-6 receptor antagonist tocilizumab became widely used early in the coronavirus disease 2019 (COVID-19) pandemic based on small observational studies that suggested clinical benefit in COVID-19 patients with a...
10.
Cornaby C, Schmitz J, Weimer E
Hum Immunol
. 2021 Sep;
82(11):829-837.
PMID: 34521569
Histocompatibility testing is essential for donor identification and risk assessment in solid organ and hematopoietic stem cell transplant. Additionally, it is useful for identifying donor specific alleles for monitoring donor...